These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19308469)

  • 1. Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.
    Mata IF; Hutter CM; González-Fernández MC; de Pancorbo MM; Lezcano E; Huerta C; Blazquez M; Ribacoba R; Guisasola LM; Salvador C; Gómez-Esteban JC; Zarranz JJ; Infante J; Jankovic J; Deng H; Edwards KL; Alvarez V; Zabetian CP
    Neurogenetics; 2009 Oct; 10(4):347-53. PubMed ID: 19308469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity.
    Gorostidi A; Ruiz-Martínez J; Lopez de Munain A; Alzualde A; Martí Massó JF
    Neurogenetics; 2009 Apr; 10(2):157-9. PubMed ID: 19020907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
    Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
    Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.
    Bar-Shira A; Hutter CM; Giladi N; Zabetian CP; Orr-Urtreger A
    Neurogenetics; 2009 Oct; 10(4):355-8. PubMed ID: 19283415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK2 R1441G in Spanish patients with Parkinson's disease.
    Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
    Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 mutations are a common cause of Parkinson's disease in Spain.
    Mata IF; Ross OA; Kachergus J; Huerta C; Ribacoba R; Moris G; Blazquez M; Guisasola LM; Salvador C; Martinez C; Farrer M; Alvarez V
    Eur J Neurol; 2006 Apr; 13(4):391-4. PubMed ID: 16643318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.
    Hatano T; Funayama M; Kubo SI; Mata IF; Oji Y; Mori A; Zabetian CP; Waldherr SM; Yoshino H; Oyama G; Shimo Y; Fujimoto KI; Oshima H; Kunii Y; Yabe H; Mizuno Y; Hattori N
    Neurobiol Aging; 2014 Nov; 35(11):2656.e17-2656.e23. PubMed ID: 24973808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetrance in Parkinson's disease related to the LRRK2 R1441G mutation in the Basque country (Spain).
    Ruiz-Martínez J; Gorostidi A; Ibañez B; Alzualde A; Otaegui D; Moreno F; López de Munain A; Bergareche A; Gómez-Esteban JC; Martí Massó JF
    Mov Disord; 2010 Oct; 25(14):2340-5. PubMed ID: 20721916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease due to the R1441G mutation in Dardarin: a founder effect in the Basques.
    Simón-Sánchez J; Martí-Massó JF; Sánchez-Mut JV; Paisán-Ruiz C; Martínez-Gil A; Ruiz-Martínez J; Sáenz A; Singleton AB; López de Munain A; Pérez-Tur J
    Mov Disord; 2006 Nov; 21(11):1954-9. PubMed ID: 16991141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.
    Ruiz-Martínez J; de la Riva P; Rodríguez-Oroz MC; Mondragón Rezola E; Bergareche A; Gorostidi A; Gago B; Estanga A; Larrañaga N; Sarasqueta C; López de Munain A; Martí Massó JF
    Mov Disord; 2014 May; 29(6):750-5. PubMed ID: 24357540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic screening for the LRRK2, G2019S and R1441 codon mutations in Parkinson's disease patients from Extremadura, Spain].
    Morán JM; Castellanos-Pinedo F; Casado-Naranjo I; Durán-Herrera C; Ramírez-Moreno JM; Gómez M; Zurdo-Hernández JM; Fuentes E; Ortiz-Ortiz MA; Moreno AD; González-Polo RA; Niso-Santano M; Bravo-Sanpedro JM; Pérez-Tur J; Ruiz-Mesa LM; Fuentes JM
    Rev Neurol; 2010 May; 50(10):591-4. PubMed ID: 20473834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
    Gao L; Gómez-Garre P; Díaz-Corrales FJ; Carrillo F; Carballo M; Palomino A; Díaz-Martín J; Mejías R; Vime PJ; López-Barneo J; Mir P
    Eur J Neurol; 2009 Aug; 16(8):957-60. PubMed ID: 19473361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
    Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
    Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.
    Goldwurm S; Di Fonzo A; Simons EJ; Rohé CF; Zini M; Canesi M; Tesei S; Zecchinelli A; Antonini A; Mariani C; Meucci N; Sacilotto G; Sironi F; Salani G; Ferreira J; Chien HF; Fabrizio E; Vanacore N; Dalla Libera A; Stocchi F; Diroma C; Lamberti P; Sampaio C; Meco G; Barbosa E; Bertoli-Avella AM; Breedveld GJ; Oostra BA; Pezzoli G; Bonifati V
    J Med Genet; 2005 Nov; 42(11):e65. PubMed ID: 16272257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease.
    Infante J; Rodríguez E; Combarros O; Mateo I; Fontalba A; Pascual J; Oterino A; Polo JM; Leno C; Berciano J
    Neurosci Lett; 2006 Mar; 395(3):224-6. PubMed ID: 16298482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic analysis of LRRK2 mutations in patients with Parkinson disease.
    Deng H; Le W; Guo Y; Hunter CB; Xie W; Huang M; Jankovic J
    J Neurol Sci; 2006 Dec; 251(1-2):102-6. PubMed ID: 17097110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic screening for the LRRK2 R1441C and G2019S mutations in Parkinsonian patients from Campania.
    De Rosa A; De Michele G; Guacci A; Carbone R; Lieto M; Peluso S; Picillo M; Barone P; Salemi F; Laiso A; Saccà F; Tessitore A; Pellecchia MT; Bonifati V; Criscuolo C
    J Parkinsons Dis; 2014; 4(1):123-8. PubMed ID: 24496098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort.
    Sadhukhan T; Vishal M; Das G; Sharma A; Mukhopadhyay A; Das SK; Ray K; Ray J
    Dis Markers; 2012; 32(6):355-62. PubMed ID: 22684232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay.
    Mata IF; Cosentino C; Marca V; Torres L; Mazzetti P; Ortega O; Raggio V; Aljanati R; Buzó R; Yearout D; Dieguez E; Zabetian CP
    Parkinsonism Relat Disord; 2009 Jun; 15(5):370-3. PubMed ID: 18980856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.